251 related articles for article (PubMed ID: 23905047)
1. Vaptans and hyponatremia in critical patients.
D'Auria D; Marinosci GZ; De Benedictis G; Piazza O
Transl Med UniSa; 2012 May; 3():1-14. PubMed ID: 23905047
[TBL] [Abstract][Full Text] [Related]
2. Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.
Urso C; Brucculeri S; Caimi G
J Clin Pharm Ther; 2015 Aug; 40(4):376-85. PubMed ID: 25924179
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients.
Nodari S; Jao GT; Chiong JR
Int J Nephrol Renovasc Dis; 2010; 3():51-60. PubMed ID: 21694929
[TBL] [Abstract][Full Text] [Related]
4. [Vasopressin antagonists in treatment of hyponatremia].
Olszewski W; Głuszek J
Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
[TBL] [Abstract][Full Text] [Related]
5. Vaptans for the treatment of hyponatremia.
Robertson GL
Nat Rev Endocrinol; 2011 Mar; 7(3):151-61. PubMed ID: 21283124
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of vasopressin receptor antagonists.
Ali F; Guglin M; Vaitkevicius P; Ghali JK
Drugs; 2007; 67(6):847-58. PubMed ID: 17428103
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin receptor antagonists and their role in clinical medicine.
Narayen G; Mandal SN
Indian J Endocrinol Metab; 2012 Mar; 16(2):183-91. PubMed ID: 22470853
[TBL] [Abstract][Full Text] [Related]
8. Management of Hyponatremia in Heart Failure: Practical Considerations.
Şorodoc V; Asaftei A; Puha G; Ceasovschih A; Lionte C; Sîrbu O; Bologa C; Haliga RE; Constantin M; Coman AE; Petriș OR; Stoica A; Şorodoc L
J Pers Med; 2023 Jan; 13(1):. PubMed ID: 36675801
[TBL] [Abstract][Full Text] [Related]
9. Role of vaptans in the management of hyponatremia.
Lehrich RW; Ortiz-Melo DI; Patel MB; Greenberg A
Am J Kidney Dis; 2013 Aug; 62(2):364-76. PubMed ID: 23725974
[TBL] [Abstract][Full Text] [Related]
10. Clinical review: the use of vaptans in clinical endocrinology.
Peri A
J Clin Endocrinol Metab; 2013 Apr; 98(4):1321-32. PubMed ID: 23401044
[TBL] [Abstract][Full Text] [Related]
11. [Current options of treatment of hyponatremia].
Tesař V
Vnitr Lek; 2016; 62 Suppl 6():97-101. PubMed ID: 28124939
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin antagonists: role in the management of hyponatremia.
Yeates KE; Morton AR
Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of SIADH.
Gross P
Ther Adv Endocrinol Metab; 2012 Apr; 3(2):61-73. PubMed ID: 23148195
[TBL] [Abstract][Full Text] [Related]
14. [Vasopressin receptor antagonists: the vaptans].
Villabona C
Endocrinol Nutr; 2010 May; 57 Suppl 2():41-52. PubMed ID: 21130961
[TBL] [Abstract][Full Text] [Related]
15. Tolvaptan in the treatment of acute hyponatremia associated with acute kidney injury.
Gopinath S; Janga KC; Greenberg S; Sharma SK
Case Rep Nephrol; 2013; 2013():801575. PubMed ID: 24558627
[TBL] [Abstract][Full Text] [Related]
16. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
Rai A; Whaley-Connell A; McFarlane S; Sowers JR
Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
[TBL] [Abstract][Full Text] [Related]
17. Hyponatremia and antidiuresis syndrome.
Vantyghem MC; Balavoine AS; Wémeau JL; Douillard C
Ann Endocrinol (Paris); 2011 Dec; 72(6):500-12. PubMed ID: 22119069
[TBL] [Abstract][Full Text] [Related]
18. Hyponatremia and the use of vasopressin receptor antagonists in critically ill patients.
Lehrich RW; Greenberg A
J Intensive Care Med; 2012; 27(4):207-18. PubMed ID: 21571754
[TBL] [Abstract][Full Text] [Related]
19. Cardiorenal Syndrome: Role of Arginine Vasopressin and Vaptans in Heart Failure.
Vinod P; Krishnappa V; Chauvin AM; Khare A; Raina R
Cardiol Res; 2017 Jun; 8(3):87-95. PubMed ID: 28725324
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hyponatremia.
Gross P
Intern Med; 2008; 47(10):885-91. PubMed ID: 18480571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]